English

CYPRESS BIOSCIENCE INC

EDGAR

Quarterly report (10-Q) · filed 2010-11-09

74 filing records in this dataset, filed from 1995-08-07 to 2010-11-09. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

8.05 million USD

2010-09-30 · USD

Exact inputs and evidence

Revenue: 8049148 USD Source

Operating margin

-499.16%

2010-09-30 · %

Exact inputs and evidence

Operating Income: -40178176 USD Source
Revenue: 8049148 USD Source

Operating cash flow

-39 million USD

2010-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -44326394 USD Source
Operating Cash Flow: -5348157 USD Source

Free cash flow

-39 million USD

2010-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -44326394 USD Source
Operating Cash Flow: -5348157 USD Source
Capital Expenditure: 143875 USD Source
Capital Expenditure: 114567 USD Source

Cash and cash equivalents: 13.9 million USD 2010-09-30 Source
Exact value

13926175 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-52.2 million USD

2009-10-01 – 2010-09-30

Exact inputs and evidence

Net income: -28251963 USD · 2009-01-01 – 2009-12-31 Source
Net income: -23238774 USD · 2009-01-01 – 2009-09-30 Source
Net income: -4567822 USD · 2010-01-01 – 2010-03-31 Source
Net income: -1791717 USD · 2010-04-01 – 2010-06-30 Source
Net income: -40821716 USD · 2010-07-01 – 2010-09-30 Source

Operating cash flow

-47 million USD

2009-10-01 – 2010-09-30

Exact inputs and evidence

Operating cash flow: -2375565 USD · 2009-01-01 – 2009-12-31 Source
Operating cash flow: 317885 USD · 2009-01-01 – 2009-09-30 Source
Operating cash flow: -3857985 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: -5348157 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: -3857985 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: -44326394 USD · 2010-01-01 – 2010-09-30 Source
Operating cash flow: -5348157 USD · 2010-01-01 – 2010-06-30 Source

Capital expenditure

154 thousand USD

2009-10-01 – 2010-09-30

Exact inputs and evidence

Capital expenditure: 652174 USD · 2009-01-01 – 2009-12-31 Source
Capital expenditure: 641639 USD · 2009-01-01 – 2009-09-30 Source
Capital expenditure: 59280 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 114567 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 59280 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 143875 USD · 2010-01-01 – 2010-09-30 Source
Capital expenditure: 114567 USD · 2010-01-01 – 2010-06-30 Source

Free cash flow

-47.2 million USD

2009-10-01 – 2010-09-30

Exact inputs and evidence

Operating cash flow: -2375565 USD · 2009-01-01 – 2009-12-31 Source
Operating cash flow: 317885 USD · 2009-01-01 – 2009-09-30 Source
Operating cash flow: -3857985 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: -5348157 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: -3857985 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: -44326394 USD · 2010-01-01 – 2010-09-30 Source
Operating cash flow: -5348157 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 652174 USD · 2009-01-01 – 2009-12-31 Source
Capital expenditure: 641639 USD · 2009-01-01 – 2009-09-30 Source
Capital expenditure: 59280 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 114567 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 59280 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 143875 USD · 2010-01-01 – 2010-09-30 Source
Capital expenditure: 114567 USD · 2010-01-01 – 2010-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2010-11-09.

Financial data available through: 2009-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2009-12-31
Operating income: 6 of 11 periods available· newest 2009-12-31
Net income: 11 of 11 periods available· newest 2009-12-31
Operating cash flow: 11 of 11 periods available· newest 2009-12-31
Capital expenditure: 11 of 11 periods available· newest 2009-12-31
Total assets: 9 of 11 periods available· newest 2009-12-31
liabilities: No compatible figures in this window
Current assets: 9 of 11 periods available· newest 2009-12-31
Current liabilities: 9 of 11 periods available· newest 2009-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2009-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+64.1%

Prior period

USD 16.66 million

2008-01-01 – 2008-12-31
Current period

USD 27.33 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

27334879 − 16659099 = 10675780 USD

16659099 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
27334879 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CYPRESS BIOSCIENCE INC · 2009-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Year-over-year change in Revenue: 10675780 USD Concept: fundies:Revenue Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 27334879 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#8927 Input fundies:Revenue: 16659099 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#8927
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 10.03 million

Prior period

−USD 18.23 million

2008-01-01 – 2008-12-31
Current period

−USD 28.25 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

-28251963 − -18225611 = -10026352 USD

-18225611 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
-28251963 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CYPRESS BIOSCIENCE INC · 2009-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Year-over-year change in Net income: -10026352 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -28251963 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10549 Input fundies:NetIncome: -18225611 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10549
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-1,128.1%

Prior period

USD 231,071

2008-01-01 – 2008-12-31
Current period

−USD 2.38 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

-2375565 − 231071 = -2606636 USD

231071 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
-2375565 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CYPRESS BIOSCIENCE INC · 2009-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Year-over-year change in Operating cash flow: -2606636 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -2375565 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10806 Input fundies:OperatingCashFlow: 231071 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10806
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-40.1%

Prior period

USD 1.09 million

2008-01-01 – 2008-12-31
Current period

USD 652,174

2009-01-01 – 2009-12-31

Exact inputs and evidence

652174 − 1089262 = -437088 USD

1089262 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
652174 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CYPRESS BIOSCIENCE INC · 2009-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Year-over-year change in Capital expenditure: -437088 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 652174 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10896 Input fundies:CapitalExpenditure: 1089262 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10896
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2009 2009-01-01 – 2009-12-31

Revenue USD 27.33 million 100% of revenue
Operating costs Derived USD 57.22 million 209% of revenue
Operating income −USD 29.89 million −109% of revenue
Tax, interest and other Derived −USD 1.63 million −6% of revenue
Net income −USD 28.25 million −103% of revenue

Cash

Operating cash flow −USD 2.38 million −8.7% of revenue
Capital expenditure USD 652,174 2.4% of revenue
Free cash flow Derived −USD 3.03 million −11% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2000 Not shown: operating income or net income is not reported.
2001 Not shown: operating income or net income is not reported.
2002 Not shown: operating income or net income is not reported.
2003 Not shown: operating income or net income is not reported.
2004 Operating loss: operating costs were 185% of revenue.
2007 Operating loss: operating costs were 128% of revenue.
2008 Operating loss: operating costs were 238% of revenue.
2009 Operating loss: operating costs were 209% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2000 2000-01-01 – 2000-12-31	2975208	Unavailable	Unavailable	Unavailable	-8502026	-7954514 Derived	Source 2000-01-01 – 2000-12-31: 2975208 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -8502026 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -7933155 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 21359 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	1600000	Unavailable	Unavailable	Unavailable	-7193628	-6926464 Derived	Source 2001-01-01 – 2001-12-31: 1600000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -7193628 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -6829511 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 96953 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	6400000	Unavailable	Unavailable	Unavailable	-1048883	-9036719 Derived	Source 2002-01-01 – 2002-12-31: 6400000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -1048883 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -9029419 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 7300 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	0	Unavailable	Unavailable	Unavailable	-21742272	-9446457 Derived	Source 2003-01-01 – 2003-12-31: 0 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -21742272 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -9413132 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 33325 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	14414619	26714108 Derived	-12299489	-1084483 Derived	-11215006	11034408 Derived	Source 2004-01-01 – 2004-12-31: 14414619 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -12299489 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -11215006 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: 11056500 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 22092 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	13440603	17238042 Derived	-3797439	-7285023 Derived	3487584	2762206 Derived	Source 2007-01-01 – 2007-12-31: 13440603 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -3797439 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: 3487584 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: 2813798 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 51592 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	16659099	39631257 Derived	-22972158	-4746547 Derived	-18225611	-858191 Derived	Source 2008-01-01 – 2008-12-31: 16659099 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -22972158 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -18225611 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: 231071 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 1089262 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	27334879	57221349 Derived	-29886470	-1634507 Derived	-28251963	-3027739 Derived	Source 2009-01-01 – 2009-12-31: 27334879 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -29886470 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -28251963 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -2375565 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 652174 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 27.3M 2009

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Revenue	1872703	Revenue: 1872703 Open source
20002000-12-31	Revenue	2975208	Revenue: 2975208 Open source
20012001-12-31	Revenue	1600000	Revenue: 1600000 Open source
20022002-12-31	Revenue	6400000	Revenue: 6400000 Open source
20032003-12-31	Revenue	0	Revenue: 0 Open source
20042004-12-31	Revenue	14414619	Revenue: 14414619 Open source
20072007-12-31	Revenue	13440603	Revenue: 13440603 Open source
20082008-12-31	Revenue	16659099	Revenue: 16659099 Open source
20092009-12-31	Revenue	27334879	Revenue: 27334879 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

64.1% 2009

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Year over year	No prior comparable period	Revenue: 1872703 Open source
20002000-12-31	Year over year	58.9%	Revenue: 2975208 Open source Revenue: 1872703 Open source
20012001-12-31	Year over year	-46.2%	Revenue: 1600000 Open source Revenue: 2975208 Open source
20022002-12-31	Year over year	300%	Revenue: 6400000 Open source Revenue: 1600000 Open source
20032003-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 6400000 Open source
20042004-12-31	Year over year	No prior comparable period	Revenue: 14414619 Open source Revenue: 0 Open source
20072007-12-31	Year over year	No prior comparable period	Revenue: 13440603 Open source
20082008-12-31	Year over year	23.9%	Revenue: 16659099 Open source Revenue: 13440603 Open source
20092009-12-31	Year over year	64.1%	Revenue: 27334879 Open source Revenue: 16659099 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -109.3% 2009

Net margin -103.4% 2009

Free cash flow margin -11.1% 2009

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1999-12-31	Operating margin	Not reported	Revenue: 1872703 Open source
2000-12-31	Operating margin	Not reported	Revenue: 2975208 Open source
2001-12-31	Operating margin	Not reported	Revenue: 1600000 Open source
2002-12-31	Operating margin	Not reported	Revenue: 6400000 Open source
2003-12-31	Operating margin	Not reported	Revenue: 0 Open source
20042004-12-31	Operating margin	-85.3%	Operating Income: -12299489 Open source Revenue: 14414619 Open source
20072007-12-31	Operating margin	-28.3%	Operating Income: -3797439 Open source Revenue: 13440603 Open source
20082008-12-31	Operating margin	-137.9%	Operating Income: -22972158 Open source Revenue: 16659099 Open source
20092009-12-31	Operating margin	-109.3%	Operating Income: -29886470 Open source Revenue: 27334879 Open source
19991999-12-31	Net margin	-415.7%	Net Income: -7784941 Open source Revenue: 1872703 Open source
20002000-12-31	Net margin	-285.8%	Net Income: -8502026 Open source Revenue: 2975208 Open source
20012001-12-31	Net margin	-449.6%	Net Income: -7193628 Open source Revenue: 1600000 Open source
20022002-12-31	Net margin	-16.4%	Net Income: -1048883 Open source Revenue: 6400000 Open source
20032003-12-31	Net margin	Not reported	Net Income: -21742272 Open source Revenue: 0 Open source
20042004-12-31	Net margin	-77.8%	Net Income: -11215006 Open source Revenue: 14414619 Open source
20072007-12-31	Net margin	25.9%	Net Income: 3487584 Open source Revenue: 13440603 Open source
20082008-12-31	Net margin	-109.4%	Net Income: -18225611 Open source Revenue: 16659099 Open source
20092009-12-31	Net margin	-103.4%	Net Income: -28251963 Open source Revenue: 27334879 Open source
19991999-12-31	Free cash flow margin	Not reported	Revenue: 1872703 Open source
20002000-12-31	Free cash flow margin	-267.4%	Revenue: 2975208 Open source Operating Cash Flow: -7933155 Open source Capital Expenditure: 21359 Open source
20012001-12-31	Free cash flow margin	-432.9%	Revenue: 1600000 Open source Operating Cash Flow: -6829511 Open source Capital Expenditure: 96953 Open source
20022002-12-31	Free cash flow margin	-141.2%	Revenue: 6400000 Open source Operating Cash Flow: -9029419 Open source Capital Expenditure: 7300 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -9413132 Open source Capital Expenditure: 33325 Open source
20042004-12-31	Free cash flow margin	76.6%	Revenue: 14414619 Open source Operating Cash Flow: 11056500 Open source Capital Expenditure: 22092 Open source
20072007-12-31	Free cash flow margin	20.6%	Revenue: 13440603 Open source Operating Cash Flow: 2813798 Open source Capital Expenditure: 51592 Open source
20082008-12-31	Free cash flow margin	-5.2%	Revenue: 16659099 Open source Operating Cash Flow: 231071 Open source Capital Expenditure: 1089262 Open source
20092009-12-31	Free cash flow margin	-11.1%	Revenue: 27334879 Open source Operating Cash Flow: -2375565 Open source Capital Expenditure: 652174 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -2.4M 2009

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Operating cash flow	Not reported	No source recorded
20002000-12-31	Operating cash flow	-7933155	Operating Cash Flow: -7933155 Open source
20012001-12-31	Operating cash flow	-6829511	Operating Cash Flow: -6829511 Open source
20022002-12-31	Operating cash flow	-9029419	Operating Cash Flow: -9029419 Open source
20032003-12-31	Operating cash flow	-9413132	Operating Cash Flow: -9413132 Open source
20042004-12-31	Operating cash flow	11056500	Operating Cash Flow: 11056500 Open source
20072007-12-31	Operating cash flow	2813798	Operating Cash Flow: 2813798 Open source
20082008-12-31	Operating cash flow	231071	Operating Cash Flow: 231071 Open source
20092009-12-31	Operating cash flow	-2375565	Operating Cash Flow: -2375565 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -3M 2009

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Free cash flow	Unavailable	No source recorded
20002000-12-31	Free cash flow	-7954514	Operating Cash Flow: -7933155 Open source Capital Expenditure: 21359 Open source
20012001-12-31	Free cash flow	-6926464	Operating Cash Flow: -6829511 Open source Capital Expenditure: 96953 Open source
20022002-12-31	Free cash flow	-9036719	Operating Cash Flow: -9029419 Open source Capital Expenditure: 7300 Open source
20032003-12-31	Free cash flow	-9446457	Operating Cash Flow: -9413132 Open source Capital Expenditure: 33325 Open source
20042004-12-31	Free cash flow	11034408	Operating Cash Flow: 11056500 Open source Capital Expenditure: 22092 Open source
20072007-12-31	Free cash flow	2762206	Operating Cash Flow: 2813798 Open source Capital Expenditure: 51592 Open source
20082008-12-31	Free cash flow	-858191	Operating Cash Flow: 231071 Open source Capital Expenditure: 1089262 Open source
20092009-12-31	Free cash flow	-3027739	Operating Cash Flow: -2375565 Open source Capital Expenditure: 652174 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1999-12-31	Liabilities / assets	Not reported	Total Assets: 12831472 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 7891271 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 6685108 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 12477519 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 23806681 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 118389524 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 182699850 Open source
2008-12-31	Liabilities / assets	Not reported	Total Assets: 174592523 Open source
2009-12-31	Liabilities / assets	Not reported	Total Assets: 176064710 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

13.18× 2009

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Current assets / current liabilities	5.17×	Current Assets: 12491274 Open source Current Liabilities: 2416728 Open source
20002000-12-31	Current assets / current liabilities	2.4×	Current Assets: 7749161 Open source Current Liabilities: 3228355 Open source
20012001-12-31	Current assets / current liabilities	0.76×	Current Assets: 6540559 Open source Current Liabilities: 8654051 Open source
20022002-12-31	Current assets / current liabilities	19.38×	Current Assets: 12316291 Open source Current Liabilities: 635427 Open source
20032003-12-31	Current assets / current liabilities	14.57×	Current Assets: 23674184 Open source Current Liabilities: 1624310 Open source
20042004-12-31	Current assets / current liabilities	21.72×	Current Assets: 118282683 Open source Current Liabilities: 5445150 Open source
20072007-12-31	Current assets / current liabilities	39.48×	Current Assets: 182600468 Open source Current Liabilities: 4624951 Open source
20082008-12-31	Current assets / current liabilities	18.44×	Current Assets: 146709153 Open source Current Liabilities: 7958031 Open source
20092009-12-31	Current assets / current liabilities	13.18×	Current Assets: 152548583 Open source Current Liabilities: 11573037 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2000 2000-01-01 – 2000-12-31	−USD 8.5 million Exact value Exact value: -8502026 USD 2000-01-01 – 2000-12-31: -8502026 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYPRESS BIOSCIENCE INC · 2000-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Net Income: -8502026 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8502026 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001193125-03-020755.txt#6233 The citation records this snapshot. The page link may show a newer release later.	−USD 7.93 million Exact value Exact value: -7933155 USD 2000-01-01 – 2000-12-31: -7933155 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYPRESS BIOSCIENCE INC · 2000-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Operating Cash Flow: -7933155 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7933155 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001193125-03-020755.txt#6443 The citation records this snapshot. The page link may show a newer release later.	USD 21,359 Exact value Exact value: 21359 USD 2000-01-01 – 2000-12-31: 21359 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYPRESS BIOSCIENCE INC · 2000-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Capital Expenditure: 21359 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 21359 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001193125-03-020755.txt#6513 The citation records this snapshot. The page link may show a newer release later.	−USD 7.95 million Calculation and evidence -7933155 − 21359 USD Exact free cash flow: -7954514 USD 2000-01-01 – 2000-12-31: -7933155 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 21359 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYPRESS BIOSCIENCE INC · 2000-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Free cash flow: -7954514 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7933155 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001193125-03-020755.txt#6443 Input fundies:CapitalExpenditure: 21359 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001193125-03-020755.txt#6513 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 7.19 million Exact value Exact value: -7193628 USD 2001-01-01 – 2001-12-31: -7193628 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYPRESS BIOSCIENCE INC · 2001-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Net Income: -7193628 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7193628 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001047469-04-009648.txt#6819 The citation records this snapshot. The page link may show a newer release later.	−USD 6.83 million Exact value Exact value: -6829511 USD 2001-01-01 – 2001-12-31: -6829511 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYPRESS BIOSCIENCE INC · 2001-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Operating Cash Flow: -6829511 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6829511 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001047469-04-009648.txt#7028 The citation records this snapshot. The page link may show a newer release later.	USD 96,953 Exact value Exact value: 96953 USD 2001-01-01 – 2001-12-31: 96953 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYPRESS BIOSCIENCE INC · 2001-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Capital Expenditure: 96953 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 96953 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001047469-04-009648.txt#7113 The citation records this snapshot. The page link may show a newer release later.	−USD 6.93 million Calculation and evidence -6829511 − 96953 USD Exact free cash flow: -6926464 USD 2001-01-01 – 2001-12-31: -6829511 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 96953 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYPRESS BIOSCIENCE INC · 2001-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Free cash flow: -6926464 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6829511 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001047469-04-009648.txt#7028 Input fundies:CapitalExpenditure: 96953 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001047469-04-009648.txt#7113 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 1.05 million Exact value Exact value: -1048883 USD 2002-01-01 – 2002-12-31: -1048883 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYPRESS BIOSCIENCE INC · 2002-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Net Income: -1048883 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1048883 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001104659-05-011236.txt#11356 The citation records this snapshot. The page link may show a newer release later.	−USD 9.03 million Exact value Exact value: -9029419 USD 2002-01-01 – 2002-12-31: -9029419 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYPRESS BIOSCIENCE INC · 2002-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Operating Cash Flow: -9029419 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9029419 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001104659-05-011236.txt#11765 The citation records this snapshot. The page link may show a newer release later.	USD 7,300 Exact value Exact value: 7300 USD 2002-01-01 – 2002-12-31: 7300 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYPRESS BIOSCIENCE INC · 2002-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Capital Expenditure: 7300 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7300 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001104659-05-011236.txt#11872 The citation records this snapshot. The page link may show a newer release later.	−USD 9.04 million Calculation and evidence -9029419 − 7300 USD Exact free cash flow: -9036719 USD 2002-01-01 – 2002-12-31: -9029419 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 7300 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYPRESS BIOSCIENCE INC · 2002-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Free cash flow: -9036719 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9029419 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001104659-05-011236.txt#11765 Input fundies:CapitalExpenditure: 7300 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001104659-05-011236.txt#11872 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 21.74 million Exact value Exact value: -21742272 USD 2003-01-01 – 2003-12-31: -21742272 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYPRESS BIOSCIENCE INC · 2003-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Net Income: -21742272 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21742272 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001104659-06-016680.txt#13342 The citation records this snapshot. The page link may show a newer release later.	−USD 9.41 million Exact value Exact value: -9413132 USD 2003-01-01 – 2003-12-31: -9413132 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYPRESS BIOSCIENCE INC · 2003-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Operating Cash Flow: -9413132 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9413132 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001104659-06-016680.txt#13753 The citation records this snapshot. The page link may show a newer release later.	USD 33,325 Exact value Exact value: 33325 USD 2003-01-01 – 2003-12-31: 33325 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYPRESS BIOSCIENCE INC · 2003-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Capital Expenditure: 33325 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 33325 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001104659-06-016680.txt#13885 The citation records this snapshot. The page link may show a newer release later.	−USD 9.45 million Calculation and evidence -9413132 − 33325 USD Exact free cash flow: -9446457 USD 2003-01-01 – 2003-12-31: -9413132 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 33325 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYPRESS BIOSCIENCE INC · 2003-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Free cash flow: -9446457 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9413132 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001104659-06-016680.txt#13753 Input fundies:CapitalExpenditure: 33325 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0001104659-06-016680.txt#13885 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 11.22 million Exact value Exact value: -11215006 USD 2004-01-01 – 2004-12-31: -11215006 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYPRESS BIOSCIENCE INC · 2004-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Net Income: -11215006 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11215006 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000936392-07-000192.txt#9600 The citation records this snapshot. The page link may show a newer release later.	USD 11.06 million Exact value Exact value: 11056500 USD 2004-01-01 – 2004-12-31: 11056500 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYPRESS BIOSCIENCE INC · 2004-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Operating Cash Flow: 11056500 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 11056500 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000936392-07-000192.txt#9838 The citation records this snapshot. The page link may show a newer release later.	USD 22,092 Exact value Exact value: 22092 USD 2004-01-01 – 2004-12-31: 22092 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYPRESS BIOSCIENCE INC · 2004-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Capital Expenditure: 22092 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 22092 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000936392-07-000192.txt#9913 The citation records this snapshot. The page link may show a newer release later.	USD 11.03 million Calculation and evidence 11056500 − 22092 USD Exact free cash flow: 11034408 USD 2004-01-01 – 2004-12-31: 11056500 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 22092 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYPRESS BIOSCIENCE INC · 2004-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Free cash flow: 11034408 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 11056500 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000936392-07-000192.txt#9838 Input fundies:CapitalExpenditure: 22092 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000936392-07-000192.txt#9913 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 7.65 million Exact value Exact value: -7650941 USD 2005-01-01 – 2005-12-31: -7650941 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYPRESS BIOSCIENCE INC · 2005-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Net Income: -7650941 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7650941 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000936392-08-000214.txt#10471 The citation records this snapshot. The page link may show a newer release later.	−USD 7.52 million Exact value Exact value: -7520866 USD 2005-01-01 – 2005-12-31: -7520866 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYPRESS BIOSCIENCE INC · 2005-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Operating Cash Flow: -7520866 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7520866 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000936392-08-000214.txt#10725 The citation records this snapshot. The page link may show a newer release later.	USD 37,536 Exact value Exact value: 37536 USD 2005-01-01 – 2005-12-31: 37536 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYPRESS BIOSCIENCE INC · 2005-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Capital Expenditure: 37536 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 37536 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000936392-08-000214.txt#10800 The citation records this snapshot. The page link may show a newer release later.	−USD 7.56 million Calculation and evidence -7520866 − 37536 USD Exact free cash flow: -7558402 USD 2005-01-01 – 2005-12-31: -7520866 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 37536 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYPRESS BIOSCIENCE INC · 2005-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Free cash flow: -7558402 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7520866 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000936392-08-000214.txt#10725 Input fundies:CapitalExpenditure: 37536 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000936392-08-000214.txt#10800 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 8.32 million Exact value Exact value: -8317677 USD 2006-01-01 – 2006-12-31: -8317677 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYPRESS BIOSCIENCE INC · 2006-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Net Income: -8317677 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8317677 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000936392-09-000124.txt#10048 The citation records this snapshot. The page link may show a newer release later.	−USD 10.46 million Exact value Exact value: -10455353 USD 2006-01-01 – 2006-12-31: -10455353 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYPRESS BIOSCIENCE INC · 2006-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Operating Cash Flow: -10455353 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10455353 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000936392-09-000124.txt#10274 The citation records this snapshot. The page link may show a newer release later.	USD 46,831 Exact value Exact value: 46831 USD 2006-01-01 – 2006-12-31: 46831 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYPRESS BIOSCIENCE INC · 2006-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Capital Expenditure: 46831 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 46831 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000936392-09-000124.txt#10364 The citation records this snapshot. The page link may show a newer release later.	−USD 10.5 million Calculation and evidence -10455353 − 46831 USD Exact free cash flow: -10502184 USD 2006-01-01 – 2006-12-31: -10455353 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 46831 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYPRESS BIOSCIENCE INC · 2006-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Free cash flow: -10502184 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10455353 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000936392-09-000124.txt#10274 Input fundies:CapitalExpenditure: 46831 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000936392-09-000124.txt#10364 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	USD 3.49 million Exact value Exact value: 3487584 USD 2007-01-01 – 2007-12-31: 3487584 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYPRESS BIOSCIENCE INC · 2007-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Net Income: 3487584 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3487584 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10549 The citation records this snapshot. The page link may show a newer release later.	USD 2.81 million Exact value Exact value: 2813798 USD 2007-01-01 – 2007-12-31: 2813798 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYPRESS BIOSCIENCE INC · 2007-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Operating Cash Flow: 2813798 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2813798 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10806 The citation records this snapshot. The page link may show a newer release later.	USD 51,592 Exact value Exact value: 51592 USD 2007-01-01 – 2007-12-31: 51592 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYPRESS BIOSCIENCE INC · 2007-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Capital Expenditure: 51592 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 51592 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10896 The citation records this snapshot. The page link may show a newer release later.	USD 2.76 million Calculation and evidence 2813798 − 51592 USD Exact free cash flow: 2762206 USD 2007-01-01 – 2007-12-31: 2813798 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 51592 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYPRESS BIOSCIENCE INC · 2007-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Free cash flow: 2762206 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2813798 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10806 Input fundies:CapitalExpenditure: 51592 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10896 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 18.23 million Exact value Exact value: -18225611 USD 2008-01-01 – 2008-12-31: -18225611 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYPRESS BIOSCIENCE INC · 2008-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Net Income: -18225611 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18225611 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10549 The citation records this snapshot. The page link may show a newer release later.	USD 231,071 Exact value Exact value: 231071 USD 2008-01-01 – 2008-12-31: 231071 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYPRESS BIOSCIENCE INC · 2008-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Operating Cash Flow: 231071 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 231071 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10806 The citation records this snapshot. The page link may show a newer release later.	USD 1.09 million Exact value Exact value: 1089262 USD 2008-01-01 – 2008-12-31: 1089262 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYPRESS BIOSCIENCE INC · 2008-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Capital Expenditure: 1089262 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1089262 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10896 The citation records this snapshot. The page link may show a newer release later.	−USD 858,191 Calculation and evidence 231071 − 1089262 USD Exact free cash flow: -858191 USD 2008-01-01 – 2008-12-31: 231071 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 1089262 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYPRESS BIOSCIENCE INC · 2008-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Free cash flow: -858191 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 231071 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10806 Input fundies:CapitalExpenditure: 1089262 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10896 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 28.25 million Exact value Exact value: -28251963 USD 2009-01-01 – 2009-12-31: -28251963 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYPRESS BIOSCIENCE INC · 2009-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Net Income: -28251963 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -28251963 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10549 The citation records this snapshot. The page link may show a newer release later.	−USD 2.38 million Exact value Exact value: -2375565 USD 2009-01-01 – 2009-12-31: -2375565 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYPRESS BIOSCIENCE INC · 2009-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Operating Cash Flow: -2375565 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2375565 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10806 The citation records this snapshot. The page link may show a newer release later.	USD 652,174 Exact value Exact value: 652174 USD 2009-01-01 – 2009-12-31: 652174 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYPRESS BIOSCIENCE INC · 2009-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Capital Expenditure: 652174 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 652174 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10896 The citation records this snapshot. The page link may show a newer release later.	−USD 3.03 million Calculation and evidence -2375565 − 652174 USD Exact free cash flow: -3027739 USD 2009-01-01 – 2009-12-31: -2375565 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 652174 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYPRESS BIOSCIENCE INC · 2009-12-31 CYPRESS BIOSCIENCE INC (edgar:716054) Free cash flow: -3027739 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/716054?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2375565 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10806 Input fundies:CapitalExpenditure: 652174 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/716054/0000950123-10-030260.txt#10896 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

74 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000716054, 716054, edgar:716054

Also known as IMRE CORP

CYPRESS BIOSCIENCE INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2009 2009-01-01 – 2009-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation